Syracuse, NY -- Syracuse’s largest nursing home is entering a new frontier of research: allowing clinical trials on ...

To systematically end active awards is a departure for NIH, which has terminated grants to Duke, UNC and RTI International.

Andrew Baum, Pfizer's chief strategy and innovation officer, talked Thursday about the pharmaceutical company's drug ...

Fire officials and hazmat teams responded to Thatcher Company of Arizona, near Southern Avenue and Rainbow Road, at 2:21 p.m.

An experimental drug appears to reduce the risk of Alzheimer's-related dementia in people destined to develop the disease in their 30s, 40s or 50s, according to the results of a new study. The ...

The move comes after a series of cuts to prevention and treatment efforts worldwide. Some functions might be moved to another ...

Forever 21 is closing stores as the fast-fashion retailer's U.S. operator is considering bankruptcy, five years after the company escaped Chapter 11, according to multiple reports. In 2020 ...

Health tech company Flatiron Health, an independent affiliate of the Roche Group, is expanding the reach of its clinical data ...

Two Post and Courier reporters exposed a history of problems and questions at Alpha Genesis in Yemassee after 43 monkeys ...

Existing research indicates that the accuracy of a Parkinson’s disease diagnosis hovers between 55% and 78% in the first five years of assessment. That’s partly because Parkinson’s sibling movement ...

An undergraduate entrepreneur’s low-cost idea is helping farmers in developing countries prevent venomous snakebites through ...

August 15, 2025, is the FDA PDUFA goal date for TNX-102 SL for the management of fibromyalgia; If approved, TNX-102 SL would become the first new ...